- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
45 Retinal Disease Trials Near You
Power is an online platform that helps thousands of Retinal Disease patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerIntravitreal Cerliponase Alfa for Batten Disease
Trial Details
Key Eligibility Criteria
5 Participants Needed
Ranibizumab PDS Implant for Diabetic Retinopathy
Trial Details
Key Eligibility Criteria
174 Participants Needed
Bevacizumab for Retinopathy of Prematurity
Trial Details
Key Eligibility Criteria
80 Participants Needed
Trial Details
Key Eligibility Criteria
660 Participants Needed
ACDN-01 for Stargardt Disease
Trial Details
Key Eligibility Criteria
13 Participants Needed
RGX-314 Gene Therapy for Wet Age-Related Macular Degeneration
Trial Details
Key Eligibility Criteria
540 Participants Needed
NG101 Gene Therapy for Age-Related Macular Degeneration
Trial Details
Key Eligibility Criteria
18 Participants Needed
Symphony Thrombectomy for Pulmonary Embolism
Trial Details
Key Eligibility Criteria
109 Participants Needed
Fenofibrate for Diabetic Retinopathy
Trial Details
Key Eligibility Criteria
560 Participants Needed
BI 764524 for Diabetic Retinopathy
Trial Details
Key Eligibility Criteria
178 Participants Needed
Faricimab or Fluocinolone Acetonide for Vision Loss
Trial Details
Key Eligibility Criteria
600 Participants Needed
KUS121 for Central Retinal Artery Occlusion
Trial Details
Key Eligibility Criteria
75 Participants Needed
VP-001 for Retinal Dystrophy
Trial Details
Key Eligibility Criteria
12 Participants Needed
Gene Therapy for Leber Congenital Amaurosis
Trial Details
Key Eligibility Criteria
34 Participants Needed
Low Vision Rehabilitation + Emotion Regulation Therapy for Visual Impairment
Trial Details
Key Eligibility Criteria
180 Participants Needed
Foselutoclax for Diabetic Macular Edema
Trial Details
Key Eligibility Criteria
52 Participants Needed
VP-001 for Retinal Dystrophy
Trial Details
Key Eligibility Criteria
12 Participants Needed
Ultevursen for Retinitis Pigmentosa
Trial Details
Key Eligibility Criteria
81 Participants Needed
Tarcocimab for Diabetic Retinopathy
Trial Details
Key Eligibility Criteria
255 Participants Needed
Oral Metformin for Stargardt Disease
Trial Details
Key Eligibility Criteria
56 Participants Needed
Why Other Patients Applied
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
MB-102 Dye for Retinal Disorders
Trial Details
Key Eligibility Criteria
10 Participants Needed
Natural History Study for Retinitis Pigmentosa
Trial Details
Key Eligibility Criteria
82 Participants Needed
Gene Therapy with SPVN06 for Cone-Rod Dystrophy
Trial Details
Key Eligibility Criteria
33 Participants Needed
Gene Therapy with Light-Stimulating Glasses for Retinitis Pigmentosa
Trial Details
Key Eligibility Criteria
15 Participants Needed
4D-150 for Age-Related Macular Degeneration
Trial Details
Key Eligibility Criteria
215 Participants Needed
VX-01 for Diabetic Retinopathy
Trial Details
Key Eligibility Criteria
100 Participants Needed
OCS-01 for Macular Edema
Trial Details
Key Eligibility Criteria
28 Participants Needed
Trial Details
Key Eligibility Criteria
72 Participants Needed
RGX-314 Gene Therapy for Diabetic Retinopathy
Trial Details
Key Eligibility Criteria
130 Participants Needed
Suprachoroidal OXU-001 vs. Intravitreal Ozurdex for Diabetic Macular Edema
Trial Details
Key Eligibility Criteria
3 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Retinal Disease clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Retinal Disease clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Retinal Disease trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Retinal Disease is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Retinal Disease medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Retinal Disease clinical trials?
Most recently, we added Robotic OCT System for Retinal Disease, VP-001 for Retinal Dystrophy and MB-102 Dye for Retinal Disorders to the Power online platform.